|
1
|
Xiao H, Tan F, Goovaerts P, et al:
Multilevel factors associated with overall mortality for men
diagnosed with prostate cancer in florida. Am J Mens Health.
8:316–326. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Gerritse FL, Meulenbeld HJ, Roodhart JM,
et al: Analysis of docetaxel therapy in elderly (≥70 years)
castration resistant prostate cancer patients enrolled in the
Netherlands Prostate Study. Eur J Cancer. 49:3176–3183. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Damaschke NA, Yang B, Bhusari S, Svaren JP
and Jarrard DF: Epigenetic susceptibility factors for prostate
cancer with aging. Prostate. 73:1721–1730. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
No authors listed. Summaries for patients.
Effect of age, tumor risk, and comorbidity on prostate cancer
survival. Ann Intern Med. 158:709–717. 2013. View Article : Google Scholar
|
|
5
|
Greenberg DC, Wright KA, Lophathanon A,
Muir KR and Gnanapragasam VJ: Changing presentation of prostate
cancer in a UK population - 10 year trends in prostate cancer risk
profiles in the East of England. Br J Cancer. 109:2115–2120. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Carter HB: American Urological Association
(AUA) guideline on prostate cancer detection: process and
rationale. BJU Int. 112:543–547. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Lamy S, Wilmart JF, Hein T, Scheiden R and
Capesius C: Prostate cancer in Luxembourg from 1982 to 2006.
Incidence and mortality. Survival of a hospital cohort. Bull Soc
Sci Med Grand Duche Luxemb. 6–19. 2013.(In French).
|
|
8
|
Peng P, Gong YM, Bao PP, et al: Estimates
and prediction of prostate cancer incidence, mortality and
prevalence in China, 2008. Zhonghua Liu Xing Bing Xue Za Zhi.
33:1056–1059. 2012.(In Chinese).
|
|
9
|
Zhang L, Wu S, Guo LR and Zhao XJ:
Diagnostic strategies and the incidence of prostate cancer: reasons
for the low reported incidence of prostate cancer in China. Asian J
Androl. 11:9–13. 2009. View Article : Google Scholar
|
|
10
|
Song FJ, Zhang BL, He M, et al: Trend
analysis of the incidence of prostate cancer in Tianjin between
1981 and 2004. Zhonghua Yi Xue Za Zhi. 90:2811–2814. 2010.(In
Chinese). PubMed/NCBI
|
|
11
|
Wang JR, Tanaka T, Zhang H, Kouno I and
Jiang ZH: Formation and conformation of baicalin-berberine and
wogonoside-berberine complexes. Chem Pharm Bull (Tokyo).
60:706–711. 2012. View Article : Google Scholar
|
|
12
|
Philogène BJ, Arnason JT, Towers GH, et
al: Berberine: A naturally occurring phototoxic alkaloid. J Chem
Ecol. 10:115–123. 1984. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Li B, Zhu WL and Chen KX: Advances in the
study of berberine and its derivatives. Yao Xue Xue Bao.
43:773–787. 2008.(In Chinese). PubMed/NCBI
|
|
14
|
Chin LW, Cheng YW, Lin SS, et al:
Anti-herpes simplex virus effects of berberine from Coptidis
rhizoma, a major component of a Chinese herbal medicine,
Ching-Wei-San. Arch Virol. 155:1933–1941. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Derosa G and Maffioli P: Alkaloids in the
nature: pharmacological applications in clinical practice of
berberine and mate tea. Curr Top Med Chem. 14:200–206. 2014.
View Article : Google Scholar
|
|
16
|
Zhang Q, Piao XL, Piao XS, Lu T, Wang D
and Kim SW: Preventive effect of Coptis chinensis and berberine on
intestinal injury in rats challenged with lipopolysaccharides. Food
Chem Toxicol. 49:61–69. 2011. View Article : Google Scholar
|
|
17
|
Yao J, Kong W and Jiang J: Learning from
berberine: Treating chronic diseases through multiple targets. Sci
China Life Sci. Oct 30–2013.(Epub ahead of print). View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Doggrell SA: Berberine - a novel approach
to cholesterol lowering. Expert Opin Investig Drugs. 14:683–685.
2005. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Affuso F, Mercurio V, Fazio V and Fazio S:
Cardiovascular and metabolic effects of Berberine. World J Cardiol.
2:71–77. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Chappell WH, Abrams SL, Franklin RA, et
al: Ectopic NGAL expression can alter sensitivity of breast cancer
cells to EGFR, Bcl-2, CaM-K inhibitors and the plant natural
product berberine. Cell Cycle. 11:4447–4461. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Yu M, Tong X, Qi B, et al: Berberine
enhances chemosensitivity to irinotecan in colon cancer via
inhibition of NFκB. Mol Med Rep. 9:249–254. 2014.
|
|
22
|
Pierpaoli E, Arcamone AG, Buzzetti F,
Lombardi P, Salvatore C and Provinciali M: Antitumor effect of
novel berberine derivatives in breast cancer cells. Biofactors.
39:672–679. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Hur JM and Kim D: Berberine inhibited
radioresistant effects and enhanced anti-tumor effects in the
irradiated-human prostate cancer cells. Toxicol Res. 26:109–115.
2010. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Bernas T and Dobrucki J: Mitochondrial and
nonmitochondrial reduction of MTT: interaction of MTT with TMRE,
JC-1, and NAO mitochondrial fluorescent probes. Cytometry.
47:236–242. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Sylvester PW: Optimization of the
tetrazolium dye (MTT) colorimetric assay for cellular growth and
viability. Methods Mol Biol. 716:157–168. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Zhou ZR, Zhu XD, Xia J, et al: Short-term
versus long-term hormone therapy plus radiotherapy or prostatectomy
for prostate cancer: a systematic review and meta-analysis. J
Cancer Res Clin Oncol. 139:783–796. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Huang ZJ, Zeng Y, Lan P, Sun PH and Chen
WM: Advances in structural modifications and biological activities
of berberine: an active compound in traditional Chinese medicine.
Mini Rev Med Chem. 11:1122–1129. 2011. View Article : Google Scholar
|
|
28
|
Pierpaoli E, Arcamone AG, Buzzetti F,
Lombardi P, Salvatore C and Provinciali M: Antitumor effect of
novel berberine derivatives in breast cancer cells. Biofactors.
39:672–679. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Goto H, Kariya R, Shimamoto M, et al:
Antitumor effect of berberine against primary effusion lymphoma via
inhibition of NF-κB pathway. Cancer Sci. 103:775–781. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Wang Z, Chen Z, Yang S, et al: Berberine
ameliorates collagen-induced arthritis in rats associated with
anti-inflammatory and anti-angiogenic effects. Inflammation.
37:1789–1798. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Barzilai A and Yamamoto K: DNA damage
responses to oxidative stress. DNA Repair (Amst). 3:1109–1115.
2004. View Article : Google Scholar
|
|
32
|
Muralimanoharan SB, Kunnumakkara AB,
Shylesh B, et al: Butanol fraction containing berberine or related
compound from nexrutine inhibits NFkappaB signaling and induces
apoptosis in prostate cancer cells. Prostate. 69:494–504. 2009.
View Article : Google Scholar :
|
|
33
|
Choi MS, Oh JH, Kim SM, et al: Berberine
inhibits p53-dependent cell growth through induction of apoptosis
of prostate cancer cells. Int J Oncol. 34:1221–1230.
2009.PubMed/NCBI
|
|
34
|
Kim JB, Lee KM, Ko E, et al: Berberine
inhibits growth of the breast cancer cell lines MCF-7 and
MDA-MB-231. Planta Med. 74:39–42. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Chidambara Murthy KN, Jayaprakasha GK and
Patil BS: The natural alkaloid berberine targets multiple pathways
to induce cell death in cultured human colon cancer cells. Eur J
Pharmacol. 688:14–21. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Yan L, Yan K, Kun W, et al: Berberine
inhibits the migration and invasion of T24 bladder cancer cells via
reducing the expression of heparanase. Tumor Biol. 34:215–221.
2013. View Article : Google Scholar
|
|
37
|
Letasiova S, Jantova S, Cipak L and
Muckova M: Berberine-antiproliferative activity in vitro and
induction of apoptosis/necrosis of the U937 and B16 cells. Cancer
Lett. 239:254–262. 2006. View Article : Google Scholar
|
|
38
|
Liu Z, Liu Q, Xu B, et al: Berberine
induces p53-dependent cell cycle arrest and apoptosis of human
osteosarcoma cells by inflicting DNA damage. Mutat Res. 662:75–83.
2009. View Article : Google Scholar : PubMed/NCBI
|
